Infringement Procedure. Eidos will promptly notify Stanford if it believes a third party infringes a Licensed Patent or if a third party files a declaratory judgment action with respect to any Licensed Patent. During the Exclusive term of this Agreement and if Eidos is developing Licensed Product, Eidos may have the right to institute a suit against or defend any declaratory judgment action initiated by this third party as provided in Section 14.4 through and including Section 14.8.
Appears in 4 contracts
Samples: Equity) Agreement, Exclusive (Equity) Agreement (BridgeBio Pharma, Inc.), Exclusive (Equity) Agreement (BridgeBio Pharma LLC)